These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3923811)

  • 21. Chronic tocainide therapy for refractory high-grade ventricular arrhythmias.
    Haffajee CI; Sacks GM; Alpert JS; Howe JP; Ockene IS; Paraskos JA; Dalen JE
    Clin Cardiol; 1983 Feb; 6(2):72-8. PubMed ID: 6403267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerance of tocainide during long-term treatment of malignant ventricular arrhythmias.
    Mohiuddin SM; Esterbrooks D; Mooss AN; Dahl JM; Hilleman DE
    Clin Cardiol; 1987 Aug; 10(8):457-62. PubMed ID: 3113792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart failure and hepatitis in a patient taking tocainide.
    Nauta IL; Ruland CM; Hertzberger DH; Rensing JB
    Int J Cardiol; 1984 Jan; 5(1):89-90. PubMed ID: 6420353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tocainide for refractory symptomatic ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1982 Apr; 49(5):1279-86. PubMed ID: 6801955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible hepatoxicity of tocainide.
    Farquhar DL; Davidson NM
    Scott Med J; 1984 Oct; 29(4):238. PubMed ID: 6442465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nodal bradycardia induced by tocainide.
    Mandal SK; Datta SK
    Postgrad Med J; 1983 Apr; 59(690):262-3. PubMed ID: 6408628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing.
    Murray KT; Barbey JT; Kopelman HA; Siddoway LA; Echt DS; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1989 May; 45(5):553-61. PubMed ID: 2498025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tocainide-induced pulmonary toxicity.
    Subauste CS; Mikell FL; Kulkarni PS; Parcon JP
    IMJ Ill Med J; 1988 Nov; 174(5):287-9. PubMed ID: 2906924
    [No Abstract]   [Full Text] [Related]  

  • 29. Paranoid psychosis induced by tocainide.
    Currie P; Ramsdale DR
    Br Med J (Clin Res Ed); 1984 Feb; 288(6417):606-7. PubMed ID: 6421396
    [No Abstract]   [Full Text] [Related]  

  • 30. Tocainide encephalopathy.
    Vincent FM; Vincent T
    Neurology; 1985 Dec; 35(12):1804-5. PubMed ID: 3934580
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe paranoia with concomitant tocainide and propranolol therapy.
    Rubino M; Jackson E
    Clin Pharm; 1982; 1(2):177-9. PubMed ID: 6821034
    [No Abstract]   [Full Text] [Related]  

  • 32. Tocainide in the cardiac ICU.
    Benning CA; Burke PA
    Crit Care Nurse; 1989 Feb; 9(2):45-53. PubMed ID: 2510974
    [No Abstract]   [Full Text] [Related]  

  • 33. Confusion and paranoia associated with oral tocainide.
    Clarke CW; el-Mahdi EO
    Postgrad Med J; 1985 Jan; 61(711):79-81. PubMed ID: 3921948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics of R- and S-tocainide in patients with acute ventricular arrhythmias.
    Thomson AH; Murdoch G; Pottage A; Kelman AW; Whiting B; Hillis WS
    Br J Clin Pharmacol; 1986 Feb; 21(2):149-54. PubMed ID: 3082345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tocainide-associated interstitial pneumonitis.
    Braude AC; Downar E; Chamberlain DW; Rebuck AS
    Thorax; 1982 Apr; 37(4):309-10. PubMed ID: 6810489
    [No Abstract]   [Full Text] [Related]  

  • 36. Tocainide-induced granulomatous hepatitis.
    Tucker LE
    JAMA; 1986 Jun; 255(24):3362. PubMed ID: 3086580
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of the value of tocainide hydrochloride in the treatment of tinnitus.
    Cathcart JM
    J Laryngol Otol; 1982 Nov; 96(11):981-4. PubMed ID: 6813410
    [No Abstract]   [Full Text] [Related]  

  • 38. Tocainide and myotonic dystrophy.
    Harries-Jones R
    J Neurol; 1986 Jun; 233(3):192. PubMed ID: 3088218
    [No Abstract]   [Full Text] [Related]  

  • 39. Irreversible interstitial pneumonitis associated with tocainide therapy.
    Van Natta B; Lazarus M; Li C
    West J Med; 1988 Jul; 149(1):91-2. PubMed ID: 3136588
    [No Abstract]   [Full Text] [Related]  

  • 40. Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success.
    Winkle RA; Mason JW; Harrison DC
    Am Heart J; 1980 Dec; 100(6 Pt 2):1031-6. PubMed ID: 6778191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.